Biotech and pharmaceuticals
In life sciences, we have a strong track record in domestic and cross-border mergers and acquisitions, helping our clients to monetise their assets through creative partnering with early-stage entrepreneurial and established companies, and by providing IP and tax advice.
Digital health
Our specialist healthcare technology practice advises the companies and investors that are transforming the way therapies and patient services are delivered.
Healthcare
In health and social care, we advise on everything from the building and operating of hospitals and care homes to the provision of new methods of diagnosis and treatment.
Insights
Life sciences and healthcare
Draghi report on EU competitiveness offers new recommendations for pharma and biotech
The former European central banker's report delivers strategic insights for pharma companies doing business in the EU
30/09/2024
Read time
4m
Life sciences and healthcare
EU competitiveness report pushes for greener and digitalised medical and IVD
The Draghi report warns of the major impact on medical device firms from digitalisation and heavy regulation
30/09/2024
Read time
4m
Connect with one of our experts
Herke van Hulst
Partner, Advocaat, The Netherlands
David Haex
Managing Partner, Belgium
